BETA

IPO registrations (S-1, F-1) · Registrants

TG THERAPEUTICS, INC.

SEC CIK
1001316 · filings on EDGAR ↗
Name on the registration
MANHATTAN PHARMACEUTICALS INC
Former names
MANHATTAN PHARMACEUTICALS INC (2003–2012); ATLANTIC TECHNOLOGY VENTURES INC (2000–2003); ATLANTIC PHARMACEUTICALS INC (1996–2000)
Registration
Form S-1, first filed 2008-05-01, last 2010-06-07; 4 initial registrations, 2 amendments
Outcome
Declared effective 2008-10-15; withdrawal requested 2009-12-22
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
2 GANSEVOORT STREET, 9TH FLOOR, New York, NY 10014
EIN
36-3898269
Ticker
TGTX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
TG THERAPEUTICS, INC. on the corporate pages

Offering terms

Shares offered
45,752,811
Listing
OTC under the symbol MHAN.OB

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 13

FiledFormWhat it isName as filedEDGAR
2008-05-01S-1S-1 (registration)MANHATTAN PHARMACEUTICALS INC0001144204-08-025564 ↗
2008-10-03S-1/AS-1/A (amendment)MANHATTAN PHARMACEUTICALS INC0001144204-08-055979 ↗
2008-10-15EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-08-003141 ↗
2009-02-23S-1S-1 (registration)MANHATTAN PHARMACEUTICALS INC0001144204-09-010382 ↗
2009-04-10S-1/AS-1/A (amendment)MANHATTAN PHARMACEUTICALS INC0001144204-09-019974 ↗
2009-04-17EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-09-000982 ↗
2009-05-15EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-09-001427 ↗
2009-06-02S-1S-1 (registration)MANHATTAN PHARMACEUTICALS INC0001144204-09-030482 ↗
2009-12-22RWRW (withdrawal request)MANHATTAN PHARMACEUTICALS INC0001144204-09-065819 ↗
2010-06-07S-1S-1 (registration)MANHATTAN PHARMACEUTICALS INC0001144204-10-032176 ↗
2010-06-18EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-10-001874 ↗
2010-07-06EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-10-002049 ↗
2010-07-06EFFECTEFFECT (declared effective)MANHATTAN PHARMACEUTICALS INC9999999995-10-002052 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2010-06-07S-1registration statement$0.0845,752,811$3,660,224OTC MHAN.OB0primary document; price line, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Herskowitz NeilDirector122006–2014
HARRIS ALAN GOfficerChief Medical Officer32006–2007
MCINERNEY TIMOTHYDirector52006–2010
WEISER MICHAELDirector; Other92006–2010
ABEL DOUGLASDirector; Director,OfficerChief Executive Officer; President and CEO82006–2010
McGuinness MichaelOfficerChief Financial Officer; COO & CFO72006–2010
Steinhart Richard IDirector32007–2010
GIMBERT JOAN PONSDirector12007
Hoenlein MalcolmDirector; Other32007–2010
Nordic Biotech Venture Fund II K/STenPercentOwner12008
MORVILLE MALCOLMDirector12010
Shimko DavidDirector22010
Opus Point Partners, LLCTenPercentOwner12012
Power Sean AOfficerCFO; CFO, Secretary and Treasurer; Chief Financial Officer332012–2026
WEISS MICHAEL SDirector,Officer; Director,Officer,TenPercentOwner; OfficerCEO; CEO and President; Chairman, Interim CEO and Pres; See Remarks282012–2026
Charney Laurence NDirector262012–2026
KENNEDY WILLIAM JAMESDirector142012–2020
SCHOENEBAUM MARKDirector92012–2018
Echelard YannDirector202012–2026
LFB Biotechnologies S.A.S.U.TenPercentOwner22012–2015
Hoberman KennethDirector132014–2026
HUME DANIELDirector132015–2026
Kolchinsky PeterTenPercentOwner22020
RA Capital Healthcare Fund LPTenPercentOwner12020
RA CAPITAL MANAGEMENT, L.P.TenPercentOwner22020
Shah Rajeev M.TenPercentOwner22020
Lonial SagarDirector122020–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2012-03-26MANHATTAN PHARMACEUTICALS INCPharmaceuticals$25,000,000$11,091,42601
2012-02-22MANHATTAN PHARMACEUTICALS INCPharmaceuticals$25,000,000$25,000,0004162

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationTG THERAPEUTICS, INC.NCState business registriesEIN (EXACT, as the state registration reports it)
Business registrationTG THERAPEUTICS, INC.NYState business registriesname and state
Form D issuerMANHATTAN PHARMACEUTICALS INCNYForm D private offeringsCIK (EXACT)
Patent assigneeTG Therapeutics, Inc.NYPatents (USPTO)name and state
SEC filerTG THERAPEUTICS, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerTG Therapeutics, Inc.NYTrademarks (USPTO)name and state
Form 5500 plan sponsorTG THERAPEUTICS, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Interests: Pharmaceutical Preparations · Health